PS Ratio Chart

View PS Ratio for GURBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2012. Start Trial.
Date Value
July 06, 2023 0.3526
July 05, 2023 0.3526
July 03, 2023 0.3526
June 30, 2023 0.3526
June 29, 2023 0.357
June 28, 2023 0.357
June 27, 2023 0.357
June 26, 2023 0.357
June 23, 2023 0.357
June 22, 2023 0.357
June 21, 2023 0.357
June 20, 2023 0.357
June 16, 2023 0.357
June 15, 2023 0.357
June 14, 2023 0.357
June 13, 2023 0.357
June 12, 2023 0.357
June 09, 2023 0.357
June 08, 2023 0.357
June 07, 2023 0.357
June 06, 2023 0.357
June 05, 2023 0.357
June 02, 2023 0.357
June 01, 2023 0.357
May 31, 2023 0.357
Date Value
May 30, 2023 0.357
May 26, 2023 0.357
May 25, 2023 0.357
May 24, 2023 0.357
May 23, 2023 0.357
May 22, 2023 0.357
May 19, 2023 0.357
May 18, 2023 0.357
May 17, 2023 0.357
May 16, 2023 0.357
May 15, 2023 0.357
May 12, 2023 0.357
May 11, 2023 0.357
May 10, 2023 0.357
May 09, 2023 0.357
May 08, 2023 0.357
May 05, 2023 0.357
May 04, 2023 0.357
May 03, 2023 0.357
May 02, 2023 0.357
May 01, 2023 0.357
April 28, 2023 0.357
April 27, 2023 0.357
April 26, 2023 0.357
April 25, 2023 0.357

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
bioMérieux SA 2.077
Théraclion SA 21.37
EDAP TMS SA --
IDEXX Laboratories, Inc. 10.09
Neogen Corp. 2.290

PS Ratio Related Metrics

Price 22.25